Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Simvastatin Treatment of Patients With Acute Optic Neuritis
RP-CARS: label-free optical readout of the myelin intrinsic healthiness.
Does lesioning surgery have a role in the management of multietiological tremor in the era of Deep Brain Stimulation?
Biomarkers of Therapeutic Response in Multiple Sclerosis: Current Status.
Biological insights from 108 schizophrenia-associated genetic loci.
Carbon Nanotube-Bilirubin Oxidase Bioconjugate as a New Biofuel Cell Label for Self-Powered Immunosensor.
Predictors of survival and functional outcomes in natalizumab-associated progressive multifocal leukoencephalopathy.
Recent imaging advances in neurology.
Decision-making under explicit risk is impaired in multiple sclerosis: relationships with ventricular width and disease disability.
IL17 Mediates Pelvic Pain in Experimental Autoimmune Prostatitis (EAP).
Myasthenia gravis complicated with optic neuritis showing anti-aquaporin 4 antibody: a case report.
Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis.
Current status of chemokines in the adult CNS.
Multiple Sclerosis (MS) as a demyelinating disease: a review on neurosurgical approaches.
The over time development of chronic illness self-management patterns: a longitudinal qualitative study.
A qualitative review of the neurophysiological underpinnings of fatigue in multiple sclerosis.
Does the immune system act as a self-organized system in multiple sclerosis?
Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque.
The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
Circadian rhythm sleep disorders in patients with multiple sclerosis and its association with fatigue: A case-control study.
Gene expression changes underlying cortical pathology: clues to understanding neurological disability in multiple sclerosis.
Pathophysiology of immune-mediated demyelinating neuropathies - Part II: Neurology.
2nd International Symposium on Gait and Balance in Multiple Sclerosis: interventions for gait and balance in MS.
Point prevalence and correlates of depression in a national community sample with multiple sclerosis.
ApoE-Deficient Promotes Blood-Brain Barrier Disruption in Experimental Autoimmune Encephalomyelitis via Alteration of MMP-9.
Pages
« first
‹ previous
…
371
372
373
374
375
376
377
378
379
…
next ›
last »